FDA Inspection 1096830 — Eurofins Biopharma Product Testing Sweden AB
The FDA completed an inspection of Eurofins Biopharma Product Testing Sweden AB on June 27, 2019 in Uppsala. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Uppsala (Sweden)